Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis

Annals of Surgical Oncology

Volumn 8, Issue 1, 2001, Pages 72-79

  Han, H ^a   Silverman, J F ^a   Santucci, T S ^a   Macherey, R S ^a   D'Amato, T A ^a   Tung, M Y ^a   Weyant, R J ^a   Landreneau, R J ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Angiolymphatic invasion; CD31; Microvessel density; Non small cell lung cancer; Vascular endothelial growth factor (VEGF)

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER STAGING; CANCER SURGERY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR CELL; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD31; CARCINOMA, NON-SMALL-CELL LUNG; ENDOTHELIAL GROWTH FACTORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; LYMPHOKINES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035155064     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2001.8.1.72     Document Type: Article

References (33)

1. Neoplasms of the lung
2. Survival in early stage non-small cell lung cancer
3. Time trends and survival after operations for primary lung cancer from 1976 through 1990
4. Non-small cell lung cancer
5. Tumor angiogenesis: Therapeutic implications
6. What is the evidence that tumors are angiogenesis dependent?
7. Angiogenesis in cancer, vascular, rheumatoid and other disease
8. Basic fibroblast growth factor induces angiogenesis in vitro
9. Intratumor microvessel density as a prognostic factor in cancer
10. Vascular endothelial growth factor is a secreted angiogenic mitogen
11. Vascular permeability factor, an endothelial cell mitogen related to PDGF
12. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms
13. Enhanced expression of vascular endothelial growth factor in metastatic melanoma
14. Vascular endothelial growth factor expression in malignant melanoma: Prognostic versus diagnostic usefulness
15. Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma
16. Intratumoral neovascularization and growth pattern in early gastric carcinoma
17. Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma
18. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer
19. Vascular endothelial growth factor expression and angiogenesis in non-small cell lung carcinomas
20. Histological typing of lung tumors
21. A new international staging system for lung cancer
22. Quantification of angiogenesis in solid human tumors: An international consensus on the methodology and criteria of evaluation
23. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors
24. Elevated vascular endothelial growth factor levels in sera of patients with lung cancer
25. The role of vascular endothelial growth factor in pathological angiogenesis
26. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma
27. Tumor angiogenesis and recurrence in stage I non-small cell lung cancer
28. Vascular endothelial growth factor expression in non-small cell lung cancer: Prognostic significance in squamous cell carcinoma
29. Relation of neovascularization to metastasis of non-small cell lung cancer
30. Tumor angiogenesis in human lung adenocarcinoma
31. Angiogenesis in malignant fibrous histiocytoma
32. Assessment of angiogenesis in breast carcinoma: An important factor in prognosis?